a profile of patients on asa or nsaids hospitalized with gastrointestinal perforations
;James D Bailey;Robert J Bailey;Richard N Fedorak
indian journal of pharmacology1995Vol. 9pp. 387-392
185
bailey1995canadiana
Abstract
BACKGROUND: In a recent clinical trial gastrointestinal tract perforations in patients on nonsteroidal anti-inflammatory drugs (NSAIDs) were found to occur with a frequency of 0.15%, and possibly to be reduced in patients concomitantly using the cytoprotective agent misoprostol.